December 10th & 11th, 2026
15th edition
MARSEILLE, FR
Stand J9

2016 Edition

Biosims Technologies

fr

Quantification of low abundance proteins in body fluids represents a promising new field to explore. To this end, Biosims has combined protein microarrays with mass spectrometry. It enables a digital quantification with an unsurpassed sensitivity allowing it to quantify protein panels down to the fg/ml range. Biosims microarrays feature multiplex spots of sandwich immunoassays, where detection antibodies are quantified using one discrete mass-tag, thus needing no fluorescence

Scroll to Top

Before you leave…

Download the official BioFIT 2026 brochure

Discover the conference programme, partnership opportunities, attendee profiles, registration options and everything you need to make the most of BioFIT 2026.